RPG Life Sciences Limited (RPGLIFE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs112.70 Million ≈ $1.22 Million USD) by net assets (Rs5.54 Billion ≈ $59.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RPGLIFE company net worth for the company's overall valuation and market capitalisation.

RPG Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency. Explore RPGLIFE cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
SAMPYO Cement Co. Ltd
KQ:038500
0.061x
Albatron Technology Co Ltd
TWO:5386
-0.135x
The Elmet Group Co. Common Stock
NASDAQ:ELMT
-0.077x
Akis Gayrimenkul Yatirim Ortakligi AS
IS:AKSGY
0.015x
Roma Green Finance Limited Ordinary Shares
NASDAQ:ROMA
-0.087x
Zhejiang Kanglongda Special
SHG:603665
0.024x
Mativ Holdings Inc.
NYSE:MATV
0.039x
Bradespar S.A
SA:BRAP3
0.000x

Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2026. View RPG Life Sciences Limited stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs6.05 Billion
≈ $65.47 Million
Rs652.80 Million
≈ $7.06 Million
0.108x -26.52%
2025-03-31 Rs5.31 Billion
≈ $57.37 Million
Rs778.60 Million
≈ $8.42 Million
0.147x -41.70%
2024-03-31 Rs3.75 Billion
≈ $40.54 Million
Rs943.60 Million
≈ $10.20 Million
0.252x -14.74%
2023-03-31 Rs3.08 Billion
≈ $33.27 Million
Rs908.20 Million
≈ $9.82 Million
0.295x +16.63%
2022-03-31 Rs2.56 Billion
≈ $27.66 Million
Rs647.50 Million
≈ $7.00 Million
0.253x -5.96%
2021-03-31 Rs2.16 Billion
≈ $23.41 Million
Rs582.70 Million
≈ $6.30 Million
0.269x -5.25%
2020-03-31 Rs1.77 Billion
≈ $19.10 Million
Rs501.70 Million
≈ $5.43 Million
0.284x -0.38%
2019-03-31 Rs1.60 Billion
≈ $17.36 Million
Rs457.80 Million
≈ $4.95 Million
0.285x +200.68%
2018-03-31 Rs1.55 Billion
≈ $16.74 Million
Rs146.80 Million
≈ $1.59 Million
0.095x +93.85%
2017-03-31 Rs1.54 Billion
≈ $16.66 Million
Rs75.40 Million
≈ $815.42K
0.049x -80.08%
2016-03-31 Rs1.34 Billion
≈ $14.45 Million
Rs328.10 Million
≈ $3.55 Million
0.246x +1660.38%
2015-03-31 Rs1.25 Billion
≈ $13.54 Million
Rs-19.70 Million
≈ $-213.05K
-0.016x +64.40%
2014-03-31 Rs1.26 Billion
≈ $13.60 Million
Rs-55.60 Million
≈ $-601.29K
-0.044x -127.36%
2013-03-31 Rs762.30 Million
≈ $8.24 Million
Rs123.20 Million
≈ $1.33 Million
0.162x -23.92%
2012-03-31 Rs741.40 Million
≈ $8.02 Million
Rs157.50 Million
≈ $1.70 Million
0.212x +10.23%
2011-03-31 Rs748.31 Million
≈ $8.09 Million
Rs144.21 Million
≈ $1.56 Million
0.193x -39.62%
2010-03-31 Rs644.31 Million
≈ $6.97 Million
Rs205.66 Million
≈ $2.22 Million
0.319x -39.17%
2009-03-31 Rs549.21 Million
≈ $5.94 Million
Rs288.19 Million
≈ $3.12 Million
0.525x -4.46%
2008-03-31 Rs492.02 Million
≈ $5.32 Million
Rs270.23 Million
≈ $2.92 Million
0.549x +166.15%
2007-03-31 Rs742.36 Million
≈ $8.03 Million
Rs153.19 Million
≈ $1.66 Million
0.206x +67.70%
2006-03-31 Rs667.72 Million
≈ $7.22 Million
Rs82.17 Million
≈ $888.59K
0.123x -71.98%
2005-03-31 Rs150.60 Million
≈ $1.63 Million
Rs66.13 Million
≈ $715.16K
0.439x --

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$501.25 Million
Rs46.35 Billion INR
Market Cap Rank
#12337 Global
#622 in India
Share Price
Rs2802.40
Change (1 day)
-0.78%
52-Week Range
Rs1744.00 - Rs3017.10
All Time High
Rs3017.10
About

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more